Synopsis
Synopsis
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Circo Maren
2. Circo-maren
3. Ergobel
4. F.i. 6714
5. Fisifax
6. Nicergobeta
7. Nicergolin Atid
8. Nicergolin Lindo
9. Nicergolin Neuraxpharm
10. Nicergolin Ratiopharm
11. Nicergolin Teva
12. Nicergolin Von Ct
13. Nicergolin-neuraxpharm
14. Nicergolin-ratiopharm
15. Nicergolin-teva
16. Nicerium
17. Nicotergoline
18. Nimergoline
19. Sermion
20. Von Ct, Nicergolin
1. 27848-84-6
2. Nimergoline
3. Ergobel
4. Nicergolinum
5. Nicotergoline
6. Sermion
7. Cergodum
8. Duracebrol
9. Nicergolent
10. Vasospan
11. Circo-maren
12. Nimergoline Base
13. Dilasenil
14. Ergotop
15. Nilogrin
16. Memoq
17. Sermion (tn)
18. 10-methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate
19. Jcv8365fwn
20. Chebi:31902
21. Nicergolin [german]
22. Nicergolina [dcit]
23. Nsc-150531
24. ((6ar,9r,10as)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methyl 5-bromonicotinate
25. Fi-6714
26. Rp 19651
27. Ncgc00017259-04
28. Nicergolinum [inn-latin]
29. Nicergolina
30. Nicergolin
31. Dsstox_cid_25607
32. Dsstox_rid_81000
33. Dsstox_gsid_45607
34. [(2s,4r,7r)-2-methoxy-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]methyl 5-bromopyridine-3-carboxylate
35. [(6ar,9r,10as)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6h-indolo[4,3-fg]quinoline-9-yl]methyl 5-bromopyridine-3-carboxylate
36. Cas-27848-84-6
37. Fi 6714
38. Sr-01000597616
39. Einecs 248-694-6
40. Unii-jcv8365fwn
41. Nsc 150531
42. Brn 4828393
43. 1-methyl-lumilysergol 8-(5-bromonicotinate) 10-methyl Ether
44. Nicergoline,(s)
45. (+)-10-methoxy-1,6-dimethylergoline-8-beta-methanol 5-bromonicotinate
46. 10-methoxy-1,6-dimethylergoline-8beta-methanol 5-bromonicotinate (ester)
47. Nicergoline [usan:inn:ban:jan]
48. 10-methoxy-1,6-dimethyl-ergolin-8-beta-methanol-(5-bromnicotinat) [german]
49. 8-beta-((5-bromonicotinoyloxy)methyl)-1,6-dimethyl-10-alpha-methoxyergoline
50. Nicergoline- Bio-x
51. Mfcd00869626
52. 10-methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyrindinecarboxylate (ester)
53. Ergoline-8-beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester)
54. Spectrum_001370
55. Nicergoline [mi]
56. 10-methoxy-1,6-dimethyl-ergolin-8-beta-methanol-(5-bromnicotinat)
57. Prestwick0_000147
58. Prestwick1_000147
59. Prestwick2_000147
60. Prestwick3_000147
61. Spectrum2_001414
62. Spectrum3_001933
63. Spectrum4_000440
64. Spectrum5_001352
65. Nicergoline [inn]
66. Nicergoline [jan]
67. 5-bromonicotinic Acid 10-methoxy-1,6-dimethylergoline-8-methyl Ester
68. Nicergoline [usan]
69. Ergoline-8-beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromonicotinate (ester)
70. Ergoline-8beta-methanol, 10-methoxy-1,6-dimethyl-, 5-bromonicotinate (ester)
71. Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, (8beta)-, 5-bromo-3-pyridinecarboxylate (ester)
72. Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8beta)-
73. Nicergoline [mart.]
74. Schembl22964
75. Bspbio_000254
76. Bspbio_003533
77. Kbiogr_000800
78. Kbioss_001850
79. Nicergoline [who-dd]
80. Divk1c_000124
81. Spectrum1501133
82. Spbio_001488
83. Spbio_002193
84. Bpbio1_000280
85. Chembl1372950
86. Dtxsid7045607
87. Hms500g06
88. Kbio1_000124
89. Kbio2_001850
90. Kbio2_004418
91. Kbio2_006986
92. Kbio3_002787
93. Nicergoline (jp17/usan/inn)
94. Nicergoline For System Suitability
95. Ninds_000124
96. Hms1568m16
97. Hms1923o09
98. Hms2089i03
99. Hms2092f07
100. Hms2095m16
101. Hms3712m16
102. Hms3886c03
103. Nicergoline [ep Monograph]
104. Nicergoline For Peak Identification
105. Pharmakon1600-01501133
106. 4-oxazolecarboxylicacid, 5-methyl-
107. Ex-a4135
108. Hy-b0702
109. Zinc3873817
110. Tox21_110810
111. Ccg-39032
112. Nsc757853
113. S4797
114. Akos005067888
115. Akos015969107
116. Tox21_110810_1
117. Db00699
118. Nicergoline 1.0 Mg/ml In Acetonitrile
119. Nsc-757853
120. Idi1_000124
121. Qtl1_000060
122. Ncgc00017259-03
123. Ncgc00017259-05
124. Ncgc00017259-07
125. Ncgc00024678-02
126. Ncgc00024678-03
127. As-12239
128. Bn166697
129. Sbi-0051652.p002
130. N0904
131. D01290
132. T72213
133. Ab00052214-04
134. Ab00052214_05
135. 848n846
136. A853601
137. Sr-05000001751
138. J-016896
139. Nicergoline, Analytical Standard, For Drug Analysis
140. Q2623398
141. Sr-01000597616-1
142. Sr-01000597616-2
143. Sr-05000001751-1
144. Brd-k76810206-001-05-7
145. Brd-k76810206-001-06-5
146. Nicergoline, European Pharmacopoeia (ep) Reference Standard
147. (8beta)-10-methoxy-1,6-dimethylergoline-8-methanol 5-bromo-3-pyridinecarboxylate (ester)
148. [(8r,10s)-10-methoxy-1,6-dimethylergolin-8-yl]methyl 5-bromopyridine-3-carboxylate
149. 10-methoxy-1,6-dimethylergoline-8.beta.-methanol 5-bromonicotinate (ester)
150. Nicergoline For Peak Identification, European Pharmacopoeia (ep) Reference Standard
151. Nicergoline For System Suitability, European Pharmacopoeia (ep) Reference Standard
152. ((6ar,9r,10as)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methyl5-bromonicotinate
153. [(6ar,9r,10as)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6h-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylate
154. 5-bromopyridine-3-carboxylic Acid [(8r,10s)-10-methoxy-1,6-dimethylergolin-8-yl]methyl Ester
155. Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, (8.beta.)-, 5-bromo-3-pyridinecarboxylate (ester)
156. Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-,5-bromo-3-pyridinecarboxylate (ester), (8b)-
Molecular Weight | 484.4 g/mol |
---|---|
Molecular Formula | C24H26BrN3O3 |
XLogP3 | 3.2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 5 |
Exact Mass | 483.11575 g/mol |
Monoisotopic Mass | 483.11575 g/mol |
Topological Polar Surface Area | 56.6 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 681 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For the treatment of senile dementia, migraines of vascular origin, transient ischemia, platelet hyper-aggregability, and macular degeneration.
Nicergoline is a potent vasodilator (improves brain blood flow). On the cerebral level it prompts a lowering of vascular resistance, an increase in arterial flow and stimulates the use of oxygen and glucose. Nicergoline also improves blood circulation in the lungs and limbs and has been shown to inhibit blood platelet aggregation.
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
C - Cardiovascular system
C04 - Peripheral vasodilators
C04A - Peripheral vasodilators
C04AE - Ergot alkaloids
C04AE02 - Nicergoline
Nicergoline acts by inhibiting the postsynaptic alpha(1)-adrenoceptors on vascular smooth muscle. This inhibits the vasoconstrictor effect of circulating and locally released catecholamines (epinephrine and norepinephrine), resulting in peripheral vasodilation. Therefore the mechanism of Nicergoline is to increase vascular circulation in the brain, thereby enhancing the transmission of nerve signals across the nerve fibres, which secrete acetylcholine as a neural transmitter.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2003-198 - Rev 05
Issue Date : 2025-01-13
Type : Chemical
Substance Number : 1998
Status : Valid
Registration Number : 306MF10154
Registrant's Address : Ostravska 305/29, Komarov, 747 70 Opava, Czech Republic
Initial Date of Registration : 2024-12-04
Latest Date of Registration :
Available Reg Filing : ASMF |
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Registration Number : 220MF10070
Registrant's Address : Ostravska 305/29, Komarov, 747 70 Opava, Czech Republic
Initial Date of Registration : 2008-02-25
Latest Date of Registration :
Available Reg Filing : ASMF |
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8266
Submission : 1989-10-17
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registrant Name : Hwanin Pharmaceutical Co., Ltd.
Registration Date : 2022-09-19
Registration Number : 20210711-209-J-1029(2)
Manufacturer Name : Teva Czech Industries sro
Manufacturer Address : Ostravska 305/29, Komarov 747 70 Opava, Czech Republic.
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Certificate Number : CEP 2023-311 - Rev 01
Issue Date : 2025-02-07
Type : Chemical
Substance Number : 1998
Status : Valid
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registrant Name : Otran Korea Co., Ltd.
Registration Date : 2023-11-21
Registration Number : 20231121-209-J-1570
Manufacturer Name : BrightGene Fine Chemical Co., Ltd.
Manufacturer Address : No. 10 Tongyuan Road, Taixing Economic Development Zone, Taizhou, Jiangsu 225400, China
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8266
Submission : 1989-10-17
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Certificate Number : CEP 2003-198 - Rev 05
Status : Valid
Issue Date : 2025-01-13
Type : Chemical
Substance Number : 1998
Certificate Number : R0-CEP 2001-107 - Rev 01
Status : Expired
Issue Date : 2005-03-10
Type : TSE
Substance Number : 1998
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2022-026 - Rev 02
Status : Valid
Issue Date : 2025-03-19
Type : Chemical
Substance Number : 1998
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2023-311 - Rev 01
Status : Valid
Issue Date : 2025-02-07
Type : Chemical
Substance Number : 1998
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Registration Number : 220MF10070
Registrant's Address : Ostravska 305/29, Komarov, 747 70 Opava, Czech Republic
Initial Date of Registration : 2008-02-25
Latest Date of Registration : 2008-02-25
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Registration Number : 306MF10154
Registrant's Address : Ostravska 305/29, Komarov, 747 70 Opava, Czech Republic
Initial Date of Registration : 2024-12-04
Latest Date of Registration : 2024-12-04
Registration Number : 218MF10446
Registrant's Address : Strada Rivoltana Km 6/7 20053 Rodano Milano Italy
Initial Date of Registration : 2006-04-27
Latest Date of Registration : 2007-12-19
Registrant Name : Otran Korea Co., Ltd.
Registration Date : 2023-11-21
Registration Number : 20231121-209-J-1570
Manufacturer Name : BrightGene Fine Chemical Co....
Manufacturer Address : No. 10 Tongyuan Road, Taixing Economic Development Zone, Taizhou, Jiangsu 225400, Chi...
Registrant Name : Sampoong Finechem Co., Ltd.
Registration Date : 2024-11-07
Registration Number : 20241107-209-J-1623
Manufacturer Name : Fuan Pharmaceutical Group Ch...
Manufacturer Address : No.1 Huanan Yi Road, Changshou District Chongqing 401254 China
Registrant Name : Palm East Co., Ltd.
Registration Date : 2025-01-07
Registration Number : 20241107-209-J-1623(2)
Manufacturer Name : Fuan Pharmaceutical Group Ch...
Manufacturer Address : No.1 Huanan Yi Road, Changshou District Chongqing 401254 China
Registrant Name : Hiple Co., Ltd.
Registration Date : 2025-01-07
Registration Number : 20241107-209-J-1623(1)
Manufacturer Name : Fuan Pharmaceutical Group Ch...
Manufacturer Address : No.1 Huanan Yi Road, Changshou District Chongqing 401254 China
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2024-11-07
Registration Number : 20241107-209-J-1715
Manufacturer Name : Kukjeon Pharmaceutical Co., ...
Manufacturer Address : 8, Balan Industrial Complex-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
Registrant Name : Ildong Pharmaceutical Co., Ltd.
Registration Date : 2021-03-23
Registration Number : 20210323-209-J-735
Manufacturer Name : OLON SPA
Manufacturer Address : Strada Rivoltana, km 6/7 20090 RODANO (MI)
Registrant Name : Ace Biopharm Co., Ltd.
Registration Date : 2022-11-02
Registration Number : 20221102-209-J-1397
Manufacturer Name : Sichuan Renan Pharmaceutical...
Manufacturer Address : No. 9, Ren'an Section, Health road, Jiulong Town (Industrial Park), Yuechi, Sichuan, ...
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2021-07-11
Registration Number : 20210711-209-J-1029
Manufacturer Name : TAPI Czech Industries sro
Manufacturer Address : Ostravska 305/29, Komarov, 747 70 Opava, Czech Republic
Registrant Name : Hanmi Pharmaceutical Co., Ltd.
Registration Date : 2022-07-01
Registration Number : 20210711-209-J-1029(1)
Manufacturer Name : Teva Czech Industries sro
Manufacturer Address : Ostravska 29/305, Komarov 747 70 Opava, Czech Republic.
Registrant Name : Hwanin Pharmaceutical Co., Ltd.
Registration Date : 2022-09-19
Registration Number : 20210711-209-J-1029(2)
Manufacturer Name : Teva Czech Industries sro
Manufacturer Address : Ostravska 305/29, Komarov 747 70 Opava, Czech Republic.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
About the Company : Lifecare Labs specializes in producing bulk drugs (APIs) and intermediates that adhere to the industry's stringent quality parameters. Its objective is to deliver excellence throug...
About the Company : Pfizer CentreOne® is an altogether different global contract development and manufacturing organization (CDMO), and a leading supplier of specialty APIs and intermediates.
...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : BrightGene Bio-Medical Technology Co., Ltd. is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special gener...
About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...
About the Company : Hainan Poly Pharm. Co., Ltd. (Poly Pharm, stock code: 300630), founded in 1992, is a high-tech enterprise specialized in the research and development, production, and sales of gene...
About the Company : Founded in 1997, Lee Pharma Limited has transformed from a small venture into a global leader in the pharmaceutical industry. Our journey began with a commitment to providing affor...
About the Company : Shenyang Syndy Pharamaceutical Co.,Ltd..mainly engage in R&D of chemical drugs and function chemicals synthesis. We have been successful in synthesis of chlorphenamine, dexbromphen...
About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Nicergoline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nicergoline manufacturer or Nicergoline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nicergoline manufacturer or Nicergoline supplier.
PharmaCompass also assists you with knowing the Nicergoline API Price utilized in the formulation of products. Nicergoline API Price is not always fixed or binding as the Nicergoline Price is obtained through a variety of data sources. The Nicergoline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N0904 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N0904, including repackagers and relabelers. The FDA regulates N0904 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N0904 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N0904 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N0904 supplier is an individual or a company that provides N0904 active pharmaceutical ingredient (API) or N0904 finished formulations upon request. The N0904 suppliers may include N0904 API manufacturers, exporters, distributors and traders.
click here to find a list of N0904 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N0904 DMF (Drug Master File) is a document detailing the whole manufacturing process of N0904 active pharmaceutical ingredient (API) in detail. Different forms of N0904 DMFs exist exist since differing nations have different regulations, such as N0904 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N0904 DMF submitted to regulatory agencies in the US is known as a USDMF. N0904 USDMF includes data on N0904's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N0904 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N0904 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The N0904 Drug Master File in Japan (N0904 JDMF) empowers N0904 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the N0904 JDMF during the approval evaluation for pharmaceutical products. At the time of N0904 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of N0904 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a N0904 Drug Master File in Korea (N0904 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of N0904. The MFDS reviews the N0904 KDMF as part of the drug registration process and uses the information provided in the N0904 KDMF to evaluate the safety and efficacy of the drug.
After submitting a N0904 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their N0904 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of N0904 suppliers with KDMF on PharmaCompass.
A N0904 CEP of the European Pharmacopoeia monograph is often referred to as a N0904 Certificate of Suitability (COS). The purpose of a N0904 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of N0904 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of N0904 to their clients by showing that a N0904 CEP has been issued for it. The manufacturer submits a N0904 CEP (COS) as part of the market authorization procedure, and it takes on the role of a N0904 CEP holder for the record. Additionally, the data presented in the N0904 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the N0904 DMF.
A N0904 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. N0904 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of N0904 suppliers with CEP (COS) on PharmaCompass.
N0904 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N0904 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N0904 GMP manufacturer or N0904 GMP API supplier for your needs.
A N0904 CoA (Certificate of Analysis) is a formal document that attests to N0904's compliance with N0904 specifications and serves as a tool for batch-level quality control.
N0904 CoA mostly includes findings from lab analyses of a specific batch. For each N0904 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N0904 may be tested according to a variety of international standards, such as European Pharmacopoeia (N0904 EP), N0904 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N0904 USP).